Interleukin-7 receptor signaling is deficient in CD4 + T Cells from HIV-infected persons and is inversely associated with aging

Journal of Infectious Diseases

Volumn 199, Issue 7, 2009, Pages 1019-1028

  Bazdar, Douglas A ^a   Kalinowska, Magdalena ^a   Sieg, Scott F ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD27 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; INTERLEUKIN 7 RECEPTOR; STAT5 PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGING; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; GENE EXPRESSION REGULATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIREMIA;

AGING; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION REGULATION; HIV INFECTIONS; HUMANS; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; VIREMIA;

EID: 65549141213     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597210     Document Type: Article

References (50)

1. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995; 181:1519-26.
2. Maraskovsky E, O'Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1mice. Cell 1997; 89: 1011-9.
3. Peschon JJ, Morrissey PJ, Grabstein KH, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994; 180:1955-60.
4. Giliani S, Mori L, de Saint Basile G, et al. Interleukin-7 receptor- (IL-7R-) deficiency: cellular and molecular bases: analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev 2005; 203:110-26.
5. Napolitano LA, Stoddart CA, Hanley MB, Wieder E, McCune JM. Effects of IL-7 on early human thymocyte progenitor cells in vitro and in SCID-hu Thy/Liv mice. J Immunol 2003; 171:645-54.
6. Okamoto Y, Douek DC, McFarland RD, Koup RA. Effects of exogenous interleukin-7 on human thymus function. Blood 2002; 99:2851-8.
7. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000; 1:426-32.
8. Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 2003; 4:680-6.
9. Tan JT, Dudl E, LeRoy E, et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A 2001; 98: 8732-7.
10. Mercier F, Boulassel MR, Yassine-Diab B, et al. Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7R- on central and effector memory CD4- and CD8- T cell subsets. Clin Exp Immunol 2008; 152:72-80.
11. Napolitano LA, Grant RM, Deeks SG, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001; 7:73-9.
12. Bazdar DA, Sieg SF. Interleukin-7 enhances proliferation responses to T-cell receptor stimulation in naive CD4- T cells from human immunodeficiency virus-infected persons. J Virol 2007; 81:12670-4.
13. Foxwell BM, Beadling C, Guschin D, Kerr I, Cantrell D. Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells. Eur J Immunol 1995; 25:3041-6.
14. Burchill MA, Goetz CA, Prlic M, et al. Distinct effects of STAT5 activation on CD4- and CD8- T cell homeostasis: development of CD4-CD25- regulatory T cells versus CD8- memory T cells. J Immunol 2003; 171:5853-64.
15. Taylor DK, Walsh PT, LaRosa DF, et al. Constitutive activation of STAT5 supersedes the requirement for cytokine and TCR engage-ment of CD4- T cells in steady-state homeostasis. J Immunol 2006; 177: 2216-23.
16. Seki Y, Yang J, Okamoto M, et al. IL-7/STAT5 cytokine signaling pathway is essential but insufficient for maintenance of naive CD4 T cell survival in peripheral lymphoid organs. J Immunol 2007; 178:262-70.
17. Yao Z, Cui Y, Watford WT, et al. Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci U S A 2006; 103:1000-5.
18. Hintzen RQ, de Jong R, Lens SM, Brouwer M, Baars P, van Lier RA. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol 1993; 151:2426-35.
19. Casazza JP, Betts MR, Price DA, et al. Acquisition of direct antiviral effector functions by CMV-specific CD4- T lymphocytes with cellular maturation. J Exp Med 2006; 203:2865-77.
20. Yue FY, Kovacs CM, Dimayuga RC, Parks P, Ostrowski MA. HIV-1-specific memory CD4- T cells are phenotypically less mature than cytomegalovirus-specific memory CD4- T cells. J Immunol 2004; 172: 2476-86.
21. Palmer BE, Blyveis N, Fontenot AP, Wilson CC. Functional and phenotypic characterization of CD57-CD4- T cells and their association with HIV-1-induced T cell dysfunction. J Immunol 2005; 175:8415-23.
22. Prince HE, York J, Jensen ER. Phenotypic comparison of the three populations of human lymphocytes defined by CD45RO and CD45RA expression. Cell Immunol 1992; 145:254-62.
23. Rethi B, Fluur C, Atlas A, et al. Loss of IL-7R- is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 2005; 19:2077-86.
24. Sasson SC, Zaunders JJ, Zanetti G, et al. Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J Infect Dis 2006; 193:505-14.
25. Park JH, Yu Q, Erman B, et al. Suppression of IL7R- transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004; 21:289-302.
26. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995; 95:2061-6.
27. Dion ML, Poulin JF, Bordi R, et al. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 2004; 21:757-68.
28. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396: 690-5.
29. Schacker TW, Brenchley JM, Beilman GJ, et al. Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4- T cells in human immunodeficiency virus type 1 infection. Clin Vaccine Immunol 2006; 13:556-60.
30. Delobel P, Nugeyre MT, Cazabat M, et al. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy. J Virol 2006; 80:10229-36.
31. Di Mascio M, Sereti I, Matthews LT, et al. Naive T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion. J Virol 2006; 80:2665-74.
32. Kovacs JA, Lempicki RA, Sidorov IA, et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med 2001; 194:1731-41.
33. Lempicki RA, Kovacs JA, Baseler MW, et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4- and CD8- T cell turnover in HIV-infected patients. Proc Natl Acad SciUSA 2000; 97:13778-83.
34. Mohri H, Perelson AS, Tung K, et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med 2001; 194:1277-87.
35. Sieg SF, Rodriguez B, Asaad R, Jiang W, Bazdar DA, Lederman MM. Peripheral S-phase T cells in HIV disease have a central memory phenotype and rarely have evidence of recent T cell receptor engagement. J Infect Dis 2005; 192:62-70.
36. Deeks SG, Kitchen CM, Liu L, et al. Immune activation set point during early HIV infection predicts subsequent CD4- T-cell changes independent of viral load. Blood 2004; 104:942-7.
37. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, Giorgi JV. Elevated CD38 antigen expression on CD8- T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4- cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:83-92.
38. Silvestri G, Sodora DL, Koup RA, et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003; 18:441-52.
39. Brenchley JM, Schacker TW, Ruff LE, et al. CD4- T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-59.
40. Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4- T cell depletion and viral replication in SIV infection. Science 1998; 280:427-31.
41. Okoye A, Meier-Schellersheim M, Brenchley JM, et al. ProgressiveCD4- central memory T cell decline results in CD4- effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 2007; 204: 2171-85.
42. Biancotto A, Grivel JC, Iglehart SJ, et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 2007; 109:4272-9.
43. Cornish AL, Chong MM, Davey GM, et al. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells. J Biol Chem 2003; 278:22755-61.
44. Fujimoto M, Naka T, Nakagawa R, et al. Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1/ suppressors of cytokine signaling-1 transgenic mice. J Immunol 2000; 165:1799-806.
45. Swainson L, Verhoeyen E, Cosset FL, Taylor N. IL-7R - gene expression is inversely correlated with cell cycle progression in IL-7-stimulated T lymphocytes. J Immunol 2006; 176:6702-8.
46. Beq S, Nugeyre MT, Ho Tsong Fang R, et al. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J Immunol 2006; 176:914-22.
47. Nugeyre MT, Monceaux V, Beq S, et al. IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virusinfected macaques. J Immunol 2003; 171:4447-53.
48. Levy Y, Weiss L, Viard JP, et al. Repeated r-hIL-7 doses improve T-cell recovery in HIV-1-infected patients enrolled in a phase I/II multicentric study [abstract 127]. In: Program and abstracts of the 14th Conference on Retroviruses and Opportunistic Infections (Los Angeles, CA), 25-28 February 2007.
49. Managlia EZ, Landay A, Al-Harthi L. Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway. Virology 2006; 350:443-52.
50. Smithgall MD, Wong JG, Critchett KE, Haffar OK. IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J Immunol 1996; 156:2324-30.